Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5.
A new preparation of trisubstituted imidazopyrazines and dihydroimidazopyrazines via parallel synthesis using aminoacids and bromoketones resulted in the discovery of non-peptidic sst5 selective agonists.